Balyasny Asset Management LLC Moderna, Inc. Call Options Transaction History

Balyasny Asset Management LLC

10 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$63.64 - $125.14 $967,328 - $1.9 Million	15,200 Added 114.29%	28,500 $1.9 Million
Q2 2024 Aug 14, 2024	BUY	$101.21 - $166.61 $1.35 Million - $2.22 Million	13,300 New	13,300 $1.58 Million
Q3 2023 Nov 14, 2023	BUY	$96.41 - $126.61 $31.3 Million - $41.1 Million	325,000 Added 250.0%	455,000 $47 Million
Q2 2023 Aug 14, 2023	BUY	$118.5 - $160.53 $15.4 Million - $20.9 Million	130,000 New	130,000 $15.8 Million
Q3 2022 Nov 14, 2022	BUY	$118.07 - $194.18 $590,350 - $970,900	5,000 New	5,000 $591,000
Q1 2022 May 16, 2022	SELL	$126.46 - $235.05 $5.31 Million - $9.87 Million	-42,000 Reduced 91.3%	4,000 $689,000
Q4 2021 Feb 14, 2022	BUY	$225.82 - $368.51 $9.82 Million - $16 Million	43,500 Added 1740.0%	46,000 $11.7 Million
Q2 2021 Aug 16, 2021	BUY	$129.91 - $234.98 $324,775 - $587,450	2,500 New	2,500 $587,000
Q3 2020 Nov 16, 2020	SELL	$54.34 - $94.85 $86.9 Million - $152 Million	-1,600,000 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$29.67 - $80.0 $47.5 Million - $128 Million	1,600,000 New	1,600,000 $103 Million

954

241M

10.6M

18.7M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $14.4B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Balyasny Asset Management LLC with notifications on news.